Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer

NCT00134355 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: PTK787

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]